Livforsakringsbolaget Skandia, Omsesidigt Boston Scientific Corp Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Boston Scientific Corp stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 43,327 shares of BSX stock, worth $3.85 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

43,327

Previous 39,223 10.46%

Holding current value

$3.85 Million

Previous $3.02 Million 20.2%

% of portfolio

0.21%

Previous 0.25%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$72.96 - $84.0 $299,427 - $344,736	4,104 Added 10.46%	43,327 $3.63 Million
Q2 2024 Jul 15, 2024	SELL	$67.33 - $77.71 $1.93 Million - $2.22 Million	-28,600 Reduced 42.17%	39,223 $3.02 Million
Q4 2023 Jan 31, 2024	BUY	$48.64 - $57.81 $91,248 - $108,451	1,876 Added 2.84%	67,823 $3.92 Million
Q3 2023 Oct 20, 2023	SELL	$50.19 - $54.68 $150,570 - $164,040	-3,000 Reduced 4.35%	65,947 $3.48 Million
Q2 2023 Jul 06, 2023	SELL	$49.72 - $54.64 $343,068 - $377,016	-6,900 Reduced 9.1%	68,947 $3.73 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $855,343 - $2.56 Million	-23,300 Reduced 23.5%	75,847 $2.94 Million
Q2 2022 Aug 16, 2022	SELL	$35.24 - $47.1 $218,488 - $292,020	-6,200 Reduced 5.89%	99,147 $3.7 Million
Q1 2022 Jun 21, 2022	BUY	$40.9 - $45.1 $126,790 - $139,810	3,100 Added 3.03%	105,347 $4.67 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $1.55 Million - $1.83 Million	40,700 Added 66.13%	102,247 $4.34 Million
Q3 2021 Oct 28, 2021	BUY	$41.23 - $45.88 $1.27 Million - $1.41 Million	30,800 Added 100.17%	61,547 $2.67 Million
Q2 2021 Jul 13, 2021	BUY	$38.58 - $44.24 $358,794 - $411,432	9,300 Added 43.36%	30,747 $1.32 Million
Q4 2020 Mar 02, 2021	BUY	$33.15 - $41.97 $222,105 - $281,199	6,700 Added 45.43%	21,447 $771,000
Q1 2020 Apr 22, 2020	BUY	$25.83 - $45.71 $111,068 - $196,553	4,300 Added 41.16%	14,747 $481,000
Q4 2019 Jan 28, 2020	SELL	$37.87 - $45.37 $196,924 - $235,924	-5,200 Reduced 33.23%	10,447 $472,000
Q2 2019 Jul 19, 2019	BUY	$34.91 - $42.98 $69,820 - $85,960	2,000 Added 14.66%	15,647 $673,000
Q1 2019 May 09, 2019	BUY	$32.91 - $40.75 $46,073 - $57,050	1,400 Added 11.43%	13,647 $524,000
Q3 2018 Oct 26, 2018	SELL	$32.83 - $38.63 $403,809 - $475,149	-12,300 Reduced 50.11%	12,247 $472,000
Q2 2018 Jul 10, 2018	BUY	$26.84 - $34.32 $99,308 - $126,984	3,700 Added 17.75%	24,547 $803,000
Q4 2017 Jan 18, 2018	SELL	$24.79 - $29.8 $126,429 - $151,980	-5,100 Reduced 19.66%	20,847 $517,000
Q3 2017 Oct 12, 2017	BUY	$26.26 - $29.17 $681,368 - $756,873	25,947	25,947 $757,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $127B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Boston Scientific Corp Transaction History